Why the study?
Does haemodialysis reduce myocardial blood flow and left ventricular function in non-diabetic patients with uneventful cardiac histories?
Does haemodialysis reduce myocardial blood flow and left ventricular function in non-diabetic patients with uneventful cardiac histories?
Haemodialysis induces a pronounced fall in myocardial blood flow even early in the procedure, providing a potential mechanism for the high cardiac event rate observed in dialysis patients.
Answers are grounded in this paper and cite their sources.
May link haemodialysis to myocardial hypoperfusion and cardiac risk; hypothesis-generating and requires prospective confirmation before practice change.
BACKGROUND: Whereas haemodialysis (HD) is lifesaving by replacement of renal function, there are data to suggest that the HD procedure itself may contribute to the high cardiac risk in dialysis patients. The HD procedure is associated with an increased risk of sudden death, and there is accumulating evidence that HD can elicit myocardial ischaemia. In this study, we evaluated the effect of HD on global and regional myocardial blood flow (MBF) and left ventricular (LV) function in non-diabetic, non-cardiac compromised patients. METHODS: (13)N-NH(3) positron emission tomography (PET) was used to quantify changes in MBF, LV wall motion, cardiac output (CO), LV end-diastolic volume (LVEDV) and end-systolic volume (LVESV) in seven non-diabetic patients with uneventful cardiac histories. PET scans were performed before and at 30 and 220 min of HD. RESULTS: In all patients global MBF fell during HD. At 30 min of HD without ultrafiltration (UF), global MBF had fallen 13.5 +/- 11.5% (P < 0.05) while CO, LVEDV and LVESV were 4.6 +/- 5.3% (NS), 5.6 +/- 4.2% (P < 0.05) and 6.9 +/- 7.2% (P < 0.05) lower, respectively. At 220 min of HD, after UF of 2.5 +/- 0.9 l, global MBF had fallen 26.6 +/- 13.9% (P < 0.05) from baseline while CO, LVEDV and LVESV were 21.0 +/- 19.7%, 31.1 +/- 12.7% and 36.4 +/- 17.5% (all P < 0.05) lower, respectively. In two patients, new LV regional wall motion abnormalities (RWMA) developed at 220 min of HD. MBF was reduced to a greater extent in regions that developed LV RWMA compared to those that did not. CONCLUSIONS: Haemodialysis induced a pronounced fall in MBF. Since MBF fell already early during HD not only hypovolaemia but also acute dialysis-associated factors seem to play a role. Haemodialysis-associated reductions in MBF may contribute to the high cardiac event rate of dialysis patients.
No takes yet. Share an insight, caveat, or question.
Dasselaar et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: